Sinovac Biotech Ltd (SVA) 5.90 $SVA Simavita Releases

New Post Public Reply Private Reply Replies (0) Message Board

Jul 31, 2016 at 11:10 PM

Sinovac Biotech Ltd (SVA) 5.90 $SVA

Simavita Releases ASX Appendix 4C for the Quarter Ended June 30, 2016
Marketwire Canada - Thu Jul 28, 9:43AM CDT
SYDNEY, AUSTRALIA--(Marketwired - Jul 28, 2016) - Simavita Limited (ASX:SVA) (TSX VENTURE:SV) ("Simavita" or the "Company"

, a global leader in the digital healthcare sector, is pleased to release its ASX Appendix 4C for the quarter ended June 30, 2016.
SV.VN: 0.050 (+0.015), SVA: 5.90 (+0.05)

Simavita Limited Voluntarily Delists From the Canadian TSX Venture Exchange
Marketwire Canada - Mon Jul 25, 7:01AM CDT
Trading to Continue on the Australian Securities Exchange
SV.VN: 0.050 (+0.015), SVA: 5.90 (+0.05)

Simavita Limited: Appointment of Company Secretary
Marketwired - Wed Jul 13, 10:56AM CDT
SYDNEY, AUSTRALIA--(Marketwired - Jul 13, 2016) - Simavita Limited ("Simavita" or the "Company"

(TSX VENTURE:SV)(ASX:SVA) advises the appointment of Nathan Bartrop as Joint Company Secretary.
SV.VN: 0.050 (+0.015), SVA: 5.90 (+0.05)

Simavita Limited: 2016 Special General Meeting Results
Marketwire Canada - Thu Jun 23, 1:20PM CDT
SYDNEY, AUSTRALIA--(Marketwired - Jun 23, 2016) - Simavita Limited ("Simavita" or the "Company"

(TSX VENTURE:SV)(ASX:SVA) is pleased to announce the results of the Special Meeting of the Company's shareholders which was held at 10:00 am today (Australian Eastern Standard Time) in Sydney, Australia. All nine resolutions that were put before the meeting were passed on a show of hands. Details of the proxy votes received by the Company in relation to each resolution in the notice of special meeting and information circular are attached.
SV.VN: 0.050 (+0.015), SVA: 5.90 (+0.05)

Global Rubella Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sinovac Biotech, Biological E, Prometheon Pharma - Research and Markets
BusinessWire - Thu Jun 09, 9:01AM CDT
Research and Markets has announced the addition of the "Rubella - Pipeline Review, H1 2016" report to their offering.
SVA: 5.90 (+0.05)

Sinovac Reports Unaudited First Quarter 2016 Financial Results
PR Newswire - Thu May 26, 5:00PM CDT
Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter ended March 31, 2016.
SVA: 5.90 (+0.05)

Sinovac to Host Conference Call to Report First Quarter of 2016 Unaudited Financial Results
PR Newswire - Fri May 20, 5:03AM CDT
Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the first quarter, ended March 31, 2016, after the market closes on Thursday, May 26, 2016. The Company will host a conference call on Friday, May 27, 2016, at 8:00 a.m. EDT (Friday, May 27, 2016 at 8:00 p.m. China Standard Time) to review the Company's financial results and provide an update on recent corporate developments.
SVA: 5.90 (+0.05)

Simavita Announces Change to the Board
Marketwire Canada - Fri May 06, 9:59AM CDT
SYDNEY, AUSTRALIA--(Marketwired - May 6, 2016) - Simavita Limited ("Simavita" or the "Company"

(TSX VENTURE:SV)(ASX:SVA) today announced that, as foreshadowed in the changes to board and management announced on April 27, 2016, Craig Holland, Non-Executive Director and Chairman of the Audit & Risk Committee has resigned from the Board of Directors effective immediately.
SV.VN: 0.050 (+0.015), SVA: 5.90 (+0.05)

Simavita Announces Changes to the Board and Management; Strong Support from Existing Shareholders for the Company; Additional Financing / Issue of Notes
Marketwired - Wed Apr 27, 7:02AM CDT
Simavita Limited ("Simavita" or the "Company"

(TSX VENTURE: SV)(ASX: SVA) today announced that the Company, supported by its major shareholders, has completed a review of its Board, operations; executive management and working capital.
RMD: 68.88 (+3.18), SV.VN: 0.050 (+0.015), SVA: 5.90 (+0.05)

Sinovac Files 2015 Annual Report on Form 20-F
PR Newswire - Tue Apr 26, 3:12AM CDT
Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that it has filed its 2015 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2015 on April 25, 2016. The Annual Report on Form 20-F is now available on the Company's website under SEC Filings in the Investor Relations section.
SVA: 5.90 (+0.05)

Sinovac Special Committee Engages Financial and Legal Advisors
PR Newswire - Thu Apr 14, 5:00AM CDT
Sinovac Biotech Ltd. ("Sinovac" or the "Company"

(NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the independent special committee of the Company's Board of Directors, formed to consider "going private" proposals received by the Company, has appointed yesterday Duff & Phelps (Duff & Phelps, LLC and Duff & Phelps Securities, LLC) as its financial advisor to assist it in this process. The special committee has also appointed Weil, Gotshal & Manges as its U.S. legal counsel, and Leslie-Ann Brissett Legal Services as its Antigua counsel. Latham & Watkins is serving as U.S. legal counsel, and Delaney Law is serving as Antigua legal counsel, to the Company.
SVA: 5.90 (+0.05)

Sinovac posts 4Q profit
Automated Insights - Tue Apr 05, 5:37AM CDT
BEIJING (AP) _ Sinovac Biotech Ltd. (SVA) on Tuesday reported fourth-quarter net income of $504,000.
SVA: 5.90 (+0.05)

Sinovac Reports Unaudited Fourth Quarter and Full Year 2015 Financial Results
PR Newswire - Tue Apr 05, 5:16AM CDT
Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and twelve month financial results for the period ended December 31, 2015.
SVA: 5.90 (+0.05)

Simavita to Integrate SIM(TM) With Leading North American Electronic Health Record Provider PointClickCare
Marketwire Canada - Mon Apr 04, 10:57AM CDT
Highlights
SV.VN: 0.050 (+0.015), SVA: 5.90 (+0.05)

Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2015 Unaudited Financial Results
PR Newswire - Tue Mar 29, 5:00AM CDT
Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and full year, ended December 31, 2015, before market opens on Tuesday, April 5, 2016. The Company will host a conference call on Tuesday, April 5, 2016, at 8:00 a.m. EDT (Tuesday, April 5, 2015 at 8:00 p.m. China Standard Time) to review the Company's financial results and provide an update on recent corporate developments.
SVA: 5.90 (+0.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial for Former OB/GYN Arthur Park Begins in Bakersfield

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Veterans Transitioning to Real Estate with Scholarships

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

New Data on SKYRIZI Offers Hope for Crohn's Patients

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Quark Baby's Milk Warmer Debut at Vancouver & Dubai

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Partner Valuation Advisors Bolsters Team with Eichman

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Celebree Gains Franchise Momentum: A New Frontier

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Omneky Outshines Competitors in AI Ad Scoring

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Honeywell Aerospace Faces Legal Turbulence in Fraud Case

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Navigating Battery Compliance for AI Data Centers

Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...

AtWork Welcomes Franchise Vet Sarah Goehring

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....